Tenet Healthcare Stock
Price
Target price
€124.00
€124.00
0.000%
-
0.000%
€129.16
07.06.24 / Tradegate
WKN: A1J5US / Symbol: THC / Name: Tenet Healthcare / Stock / Healthcare Providers & Services / Mid Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Tenet Healthcare Stock
There is no change in the price for Tenet Healthcare today.
The stock is an absolute favorite of our community with 32 Buy predictions and no Sell predictions.
As a result the target price of 129 € shows a slightly positive potential of 4.03% compared to the current price of 124.0 € for Tenet Healthcare.
Pros and Cons of Tenet Healthcare in the next few years
Pros
?
C******** o* t** e**********
?
S********** s********
?
G***** c******* t* c**********
Cons
?
M***** P*******
?
W********* I********* f** t** n*** y****
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Tenet Healthcare vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Tenet Healthcare | 0.000% | 0.813% | 8.772% | 79.710% | 79.710% | 122.701% | 590.577% |
| Amn Healthcare Svs | 0.830% | -2.823% | -11.560% | -49.263% | -28.060% | -36.159% | 7.266% |
| Ensign Group Inc. | 0.910% | -1.786% | 0.917% | - | 6.796% | - | - |
| Chemed Corp. | -0.800% | 1.215% | -4.762% | - | - | - | - |
Comments
Tenet Healthcare Co. (NYSE: THC) was upgraded by analysts at Baird R W to a "strong-buy" rating.
Show more
Ratings data for THC provided by MarketBeat
Tenet Healthcare Co. (NYSE: THC) had its price target raised by analysts at JPMorgan Chase & Co. from $107.00 to $140.00. They now have an "overweight" rating on the stock.
Show more
Ratings data for THC provided by MarketBeat
Tenet Healthcare Co. (NYSE: THC) had its price target raised by analysts at Deutsche Bank Aktiengesellschaft from $126.00 to $150.00. They now have a "buy" rating on the stock.
Show more
Ratings data for THC provided by MarketBeat
